Health System

Software manages and tracks every IV dose administered by hospitals

New products include brand-name drugs, generics, home-health products, over-the-counter, and health and beauty care.

Two out of 10 hospital pharmacists know of incidents in which inadequate policies have led to patient harm, an exclusive Drug Topics survey concluded.

The idea of a major new center to support studies comparing drugs and other medical interventions in head-to-head research has gained surprising focus in health policy discussions.

ACCP's Public and Professional Affairs Committee presented its new position paper.

Concurrent use of duloxetine and eletriptan increases the risk of serotonin syndrome.

The FDA has granted approval to a new form of sevelamer, a phosphate binder used to treat patients with chronic kidney disease who are on dialysis.

Updated guidelines address tumors arising in the lip, oral cavity, oropharynx, hypopharynx, glottic and supraglottic larynx, paranasal sinuses, nasopharynx, and salivary glands.

A prevailing operational relationship with his pharmacy department was a major factor in winning a prestigious safety and quality award.

Doribax (doripenem for injection), a broad spectrum antibiotic, was recently approved by the FDA for the treatment of complicated intra-abdominal and complicated urinary tract infections.

Hospitals concerned about their infection rates may want to consider the use of a new pain relief device that potentially offers a two-pronged benefit – the reduction of pain and surgical site infections.

Hospital reduces medical errors with automatic drug dispensing/distribution system.

Medication reconciliation is important to patient safety and should be overseen by hospital pharmacists, but relatively few pharmacists have time to counsel patients.

New technology designed to boost 340B participation

Medco announces its plans to build a 318,000-sq. ft. mail-order pharmacy in Indiana.

New delivery device approved for somatropin (Saizen).

A new study finds that Retail clinic's revenues could reach nearly $4.5 billion by 2011.

Union protest targets Rite Aid.

New drugs, generics, dosages and indications

Efforts to educate others about Alzheimer's disease earns hospital pharmacist Eisai award.

Three pharmacists are the proud recipients of Eisai's hhc (human health care) Pharmacist Recognition Award.

FDA approves new form of sevelamer for chronic kidney disease

An examination of data in Michigan reveals that e-prescribing reduces potential drug interaction problems.

Bayer issues a guidance on Trasylol, stating that it should only be used as directed on its label.

PBMI says employers' drug cost increase remains in single digits.